Related Experiment Video
Updated: May 28, 2025

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
Published on: January 4, 2018
Orexin/hypocretin receptor 2 signaling in MCH neurons regulates REM sleep and insulin sensitivity
Shuntaro Izawa1, Debora Fusca2, Hong Jiang3
1Department of Neuronal Control of Metabolism, Max Planck Institute for Metabolism Research, Cologne, Germany; Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases (CECAD) and Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany; Policlinic for Endocrinology, Diabetes, and Preventive Medicine (PEDP), University Hospital Cologne, Kerpener Str. 62, 50937 Cologne, Germany.
Abstract:
Orexin/hypocretin receptor type 2 (Ox2R), which is widely expressed in the brain, receives orexin signals and modulates sleep and metabolism. Ox2R selective agonists are currently under clinical trials for narcolepsy treatment. Here, we focused on Ox2R expression and function in melanin-concentrating hormone (MCH) neurons, which have opposite roles to orexin neurons in sleep and metabolism regulation. Ox2R-expressing MCH neurons showed heterogeneity of RNA expression, and orexin B application in brain slices induced both excitatory and inhibitory responses in distinct MCH neuron populations. Ox2R inactivation in MCH neurons reduced transitions from non-rapid eye movement (NREM) to REM sleep and impaired insulin sensitivity with excessive feeding after a fasting period in female mice. In conclusion, Ox2R mediates excitatory and inhibitory responses in MCH neuron sub-populations in vivo, which regulate sleep and metabolism in female mice.
Insights
Orexin/hypocretin receptor type 2 (Ox2R) in melanin-concentrating hormone (MCH) neurons impacts sleep and metabolism. Ox2R inactivation in MCH neurons disrupts sleep transitions and impairs metabolic regulation in female mice.
Area of Science:
- Neuroscience
- Endocrinology
- Sleep Medicine
Background:
- Orexin/hypocretin receptor type 2 (Ox2R) is crucial for regulating sleep and metabolism.
- Ox2R selective agonists are being developed for narcolepsy treatment.
- Melanin-concentrating hormone (MCH) neurons have opposing roles to orexin neurons in sleep and metabolism.
Purpose of the Study:
- To investigate the expression and function of Ox2R in MCH neurons.
- To understand how Ox2R signaling in MCH neurons influences sleep-wake cycles and metabolic processes.
- To explore the heterogeneity of Ox2R-expressing MCH neurons.
Main Methods:
- Analysis of RNA expression in Ox2R-expressing MCH neurons.
- Electrophysiological recordings in brain slices to assess orexin B effects on MCH neurons.
- Genetic inactivation of Ox2R in MCH neurons in female mice.
- Assessment of sleep patterns (NREM/REM transitions) and metabolic parameters (insulin sensitivity, feeding behavior).
Main Results:
- Ox2R-expressing MCH neurons exhibit heterogeneous RNA expression.
- Orexin B elicits both excitatory and inhibitory responses in distinct MCH neuron populations.
- Ox2R inactivation in MCH neurons reduced NREM to REM sleep transitions.
- Impaired insulin sensitivity and excessive feeding were observed after Ox2R inactivation in MCH neurons in female mice.
Conclusions:
- Ox2R plays a dual role (excitatory and inhibitory) in MCH neuron sub-populations.
- Ox2R signaling within MCH neurons is vital for regulating sleep architecture and metabolic homeostasis in female mice.
Related Concept Videos
Regulation of Food Intake
Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Insulin: The Receptor and Signaling Pathways
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Management of Insomnia
Narcolepsy

